SCHEMBL8095384

SCHEMBL8095384

CCCCC(S)CC(CCCCC(=O)O)C(=S)CCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 2/20 0.44
FFAR1 O14842 2/20 0.44
AKR1B1 P15121 1/20 0.42
KMT2A Q03164 2/20 0.41
MAPT P10636 1/20 0.41
GPR84 Q9NQS5 7/20 0.41
PPARG P37231 7/20 0.41
PPARD Q03181 7/20 0.41
PPARA Q07869 7/20 0.41
HDAC11 Q96DB2 5/20 0.41
TSHR P16473 4/20 0.41
PTPN1 P18031 3/20 0.41
ALDH1A1 P00352 3/20 0.41
TLR2 O60603 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
FABP4 P15090 2/20 0.41
SLC22A6 Q4U2R8 1/20 0.41
SLC22A8 Q8TCC7 1/20 0.41
MEN1 O00255 1/20 0.41
ESR1 P03372 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7784240 0.79 FOLH1 (0.45) FFAR4FFAR1AKR1B1KMT2AMAPT
SCHEMBL11749293 0.78 FFAR4 (0.69) FFAR4FFAR1AKR1B1KMT2AMAPT
SCHEMBL12384963 0.78 FFAR4 (0.69) FFAR4FFAR1AKR1B1KMT2AMAPT
SCHEMBL29962629 0.78 FFAR4 (0.69) FFAR4FFAR1AKR1B1KMT2AMAPT
SCHEMBL10942819 0.78 FFAR4 (0.69) FFAR4FFAR1AKR1B1KMT2AMAPT
SCHEMBL12506523 0.78 FFAR4 (0.69) FFAR4FFAR1AKR1B1KMT2AMAPT
SCHEMBL2349520 0.78 FFAR4 (0.69) FFAR4FFAR1AKR1B1KMT2AMAPT
SCHEMBL21772258 0.78 FFAR4 (0.69) FFAR4FFAR1AKR1B1KMT2AMAPT
SCHEMBL3249933 0.78 AKR1B1 (0.56) FFAR4FFAR1AKR1B1KMT2AMAPT
SCHEMBL3253370 0.78 AKR1B1 (0.56) FFAR4FFAR1AKR1B1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6117902-A 6,8-dimercaptooctanoic acid derivatives substituted at the 6-S and/or 8-S position with the (3-methylthiopropanoyl) radical and pharmaceutical compositions intended for the treatment of cancerous tumors GALDERMAN RESEARCH & DEVELOPMENT, S.N.C. SOPHIA ABTIPOLIS (FR) 2000-09-12 US disclosed